ECMO registry study in Martinique
Part of Blood & lymphatic, Genetic & congenital, Heart & circulation, Infections, Lungs & breathing clinical trials.
This study collects information from patients who have been treated with a heart-lung support machine called ECMO at the University Hospital of Martinique since 2010. The goal is to learn more about the outcomes of this treatment for patients with severe lung or heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were treated with a type of ECMO that supports the lungs (veno-venous ECMO) or another type of ECMO by the HeartTeam at the University Hospital of Martinique.
- Your treatment was given at any time since January 2010.
- Your medical records include the main information needed for the study and at least 80% of other important details.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether using a life-support machine called ECMO (extra support for the heart and lungs) helps people who develop shock right after a heart attack. It aims to improve outcomes when blood flow is failing and organs may be struggling.
This is a research registry for adults who need a breathing and/or heart support machine called ECMO while in the hospital. It collects information to better understand who receives ECMO and how patients do over time.
This registry collects information about people who are placed on ECMO, a heart-lung machine used to support breathing and/or circulation. It may help doctors better understand who benefits and how to manage ECMO in the future.
This study tests a specific heart-lung machine called Cardiohelp to help children with severe heart failure. It looks at how well the machine works and whether a blood thinner (either heparin or bivalirudin) is safer and more effective.
This study is a registry that collects information from adults who need a temporary heart circulation support device such as VA-ECMO or an Impella pump (or newer similar devices). It may help doctors better understand which patients benefit most and how these devices are used in real life.
This trial looks at using a specific heart-lung support machine (the EUROSETS ECMOLIFE system) for adults who need urgent “extra” circulation support. It may help clinicians understand how well the device works in serious situations like shock, cardiac arrest, or after heart surgery.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.